2020
DOI: 10.1016/j.stemcr.2020.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Histone Modifications in Stem Cell Development and Their Clinical Implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 77 publications
0
13
0
Order By: Relevance
“…Recently, studies have been suggested that epigenetic changes such as DNA methylation and histone modifications enhance the events of BCSC metastasis [126][127][128]. miRNAs are epigenetic modulators that target mRNAs without modifying the gene sequences [129,130].…”
Section: Signaling Pathways Induced By Mirnas In Bcscsmentioning
confidence: 99%
“…Recently, studies have been suggested that epigenetic changes such as DNA methylation and histone modifications enhance the events of BCSC metastasis [126][127][128]. miRNAs are epigenetic modulators that target mRNAs without modifying the gene sequences [129,130].…”
Section: Signaling Pathways Induced By Mirnas In Bcscsmentioning
confidence: 99%
“…Eukaryotic gene expression is regulated by chromatin regulators (CRs) and the histone and DNA modifications they read, write, and remove ( Bannister and Kouzarides, 2011 ; Zhang et al, 2016 ). Chromatin-mediated gene regulation is crucial in development, aging, and disease ( Jambhekar et al, 2019 ; Völker-Albert et al, 2020 ; Zhao and Shilatifard, 2019 ), with classical examples of X-chromosome inactivation and the spatial-temporal control of Hox genes ( Soshnikova and Duboule, 2009 ; Payer, 2017 ). It is also important in synthetic biology, where precise control of gene expression is necessary for probing gene regulatory networks with CRISPRi type screens, for better understanding mechanisms of epigenetic regulation such as cellular reprogramming, and for therapeutic applications such as gene therapy ( Keung et al, 2015 ; Thakore et al, 2016 ; Lienert et al, 2014 ).…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, bulk methodologies have been indispensable tools for our current understanding of epigenetics and its relationship with cancer. For example, they allowed for the methylation-based classification of diffuse gliomas (LGm1-LGm6) [135], the potential classification of cancers of unknown primary [123], and the histone modificationbased tracking of cell differentiation states [136].…”
Section: Tumor Heterogeneity and Its Relation To Epigenetic Alterationsmentioning
confidence: 99%